Compare Abbott Laboratories (ABT) vs Waste Management, Inc. (WM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Waste Management, Inc. — how do they compare? Abbott Laboratories trades at $95.81 (market cap $166.94B), while Waste Management, Inc. trades at $236.52 (market cap $95.26B). The key difference: Abbott Laboratories is the larger of the two by market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | WM | |
|---|---|---|
Market Cap | $166.94B | $95.26B |
Sector | Health | Industrials |
52-Week High | $136.62 | $246.51 |
52-Week Low | $82.57 | $196.77 |
Enterprise Value | $193.69B | $117.99B |
Dividend Yield | 2.63% | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
WM trades at $237.21, up 2.96% today and near its 52-week high of $248.13. The stock shows bullish technical signals with strong moving averages and positive momentum indicators. Fundamentally, revenue grew to $25.20B in 2025 with a net income margin of 10.99%, though recent quarters saw mixed earnings results. Analyst consensus is bullish with a $261 price target, and the company maintains a solid dividend with recent payout of $0.95 per share.
Outlook remains positive driven by pricing discipline and renewable energy initiatives, but risks include elevated valuation multiples and debt levels. The stock offers stability through economic cycles but faces execution risks in maintaining margin growth amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
